Literature DB >> 32877803

Insights of tankyrases: A novel target for drug discovery.

Manoj G Damale1, Shahebaaz K Pathan2, Devanand B Shinde3, Rajendra H Patil4, Rohidas B Arote5, Jaiprakash N Sangshetti6.   

Abstract

Tankyrases are the group of enzymes belonging to a class of Poly (ADP-ribose) polymerase (PARP) recently named ADP-ribosyltransferase (ARTD). The two isoforms of tankyrase i.e. tankyrase1 (TNKS1) and tankyrase2 (TNKS2) were abundantly expressed in various biological functions in telomere regulation, Wnt/β-catenin signaling pathway, viral replication, endogenous hormone regulation, glucose transport, cherubism disease, erectile dysfunction, and apoptosis. The structural analysis, mechanistic information, in vitro and in vivo studies led identification and development of several classes of tankyrase inhibitors under clinical phases. In the nutshell, this review will drive future research on tankyrase as it enlighten the structural and functional features of TNKS 1 and TNKS 2, different classes of inhibitors with their structure-activity relationship studies, molecular modeling studies, as well as past, current and future perspective of the different class of tankyrase inhibitors.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer; Antidiabetic; Antiviral; Clinical phases and inhibitors; Dysplasia; Hormonal; Tankyrases

Mesh:

Substances:

Year:  2020        PMID: 32877803     DOI: 10.1016/j.ejmech.2020.112712

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

Review 1.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

2.  MicroRNA-490-3p inhibits migration and chemoresistance of colorectal cancer cells via targeting TNKS2.

Authors:  Jing Li; Rubing Mo; Linmei Zheng
Journal:  World J Surg Oncol       Date:  2021-04-13       Impact factor: 2.754

3.  Tankyrase Inhibitor for Cardiac Tissue Regeneration: an In-silico Approach.

Authors:  Faezeh Sadat Hosseini; Arash Amanlou; Massoud Amanlou
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

4.  Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.

Authors:  Jan Homann; Tim Osburg; Olena Ohlei; Valerija Dobricic; Laura Deecke; Isabelle Bos; Rik Vandenberghe; Silvy Gabel; Philip Scheltens; Charlotte E Teunissen; Sebastiaan Engelborghs; Giovanni Frisoni; Olivier Blin; Jill C Richardson; Regis Bordet; Alberto Lleó; Daniel Alcolea; Julius Popp; Christopher Clark; Gwendoline Peyratout; Pablo Martinez-Lage; Mikel Tainta; Richard J B Dobson; Cristina Legido-Quigley; Kristel Sleegers; Christine Van Broeckhoven; Michael Wittig; Andre Franke; Christina M Lill; Kaj Blennow; Henrik Zetterberg; Simon Lovestone; Johannes Streffer; Mara Ten Kate; Stephanie J B Vos; Frederik Barkhof; Pieter Jelle Visser; Lars Bertram
Journal:  Front Aging Neurosci       Date:  2022-03-21       Impact factor: 5.750

Review 5.  Functions of ADP-ribose transferases in the maintenance of telomere integrity.

Authors:  Daniela Muoio; Natalie Laspata; Elise Fouquerel
Journal:  Cell Mol Life Sci       Date:  2022-03-29       Impact factor: 9.207

6.  Green Synthesis and Anticancer Potential of 1,4-Dihydropyridines-Based Triazole Derivatives: In Silico and In Vitro Study.

Authors:  Sabera Bijani; Danish Iqbal; Sheefa Mirza; Vicky Jain; Sadaf Jahan; Mohammed Alsaweed; Yahya Madkhali; Suliman A Alsagaby; Saeed Banawas; Abdulrahman Algarni; Faris Alrumaihi; Rakesh M Rawal; Wael Alturaiki; Anamik Shah
Journal:  Life (Basel)       Date:  2022-03-31

7.  The C. elegans Observatory: High-throughput exploration of behavioral aging.

Authors:  Rex A Kerr; Antoine E Roux; Jérôme Goudeau; Cynthia Kenyon
Journal:  Front Aging       Date:  2022-08-29

Review 8.  ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.

Authors:  Giuseppe Manco; Giuseppina Lacerra; Elena Porzio; Giuliana Catara
Journal:  Biomolecules       Date:  2022-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.